Summarizes the history of Eli Lilly's innovation in the business, describing the dimensions by which innovations have been made in the industry has changed. Lilly's innovation strategy has been to carry out higher and higher performance products, and others in the industry spend more convenient products. At the time of the case, Lilly is considering the provision of services, not just products, diabetic patients. "Hide
by Clayton M. Christensen Source: Harvard Business School 16 pages. Publication Date: February 8, 1996. Prod. #: 696077-PDF-ENG
Related Case Solutions & Analyses:
General Electric’s Expansion in the Middle East
Nasty Gals Do It Better
Asking “What Else?” to Identify Unintended Negative Consequences
Coca-Cola and Huiyuan (A): Antitrust Barriers to Buying Top Chinese Brands
Fighting a Dangerous Financial Fire: The Federal Response to the Crisis of 2007-2009, Chinese Version
Nestle SA: Nutrition, Health and Wellness Strategy, Portuguese Version
Netflix Leading with Data: The Emergence of Data-Driven Video
Union Carbide’s Bhopal Plant (A)
China and the WTO: Doing the Right Thing? (Abridged)
IDD Connection Between a Reform-in-Progress China and a Deregulated Hong KongIDD Connection Between a Reform-in-Progress China and a Deregulated Hong Kong
